LivaNova Perceval Sutureless Heart Valve 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 LivaNova 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2018-06-25
  • 사례 출판 날짜
    2018-06-25
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: livanova perceval sutureless heart valve medical device manufacturer, livanova, has issued a medical device safety alert concerning its perceval sutureless heart valve. the affected products are identified as follow: perceval sutureless aortic heart valve size s, item number: icv1208, reference: pcs21 perceval sutureless aortic heart valve size m, item number: icv1209, reference: pvs23 perceval sutureless aortic heart valve size l, item number: icv1210, reference: pvs25 perceval sutureless aortic heart valve size xl, item number: icv1211, reference: pvs27 the manufacturer has recently become aware, through its post-market surveillance processes, of more than anticipated cases of valve insufficiency, primarily caused by oversizing leading to “stent folding”, which is defined as an inward deformation of the stent at the annulus level. according to the manufacturer, in the past 10 years, 49 complaints related to perceval folding were reported, with an increase in the number of cases in 2017. although the event has been observed with all prosthesis sizes, it has been more frequently reported with sizes s and m. moreover, patients with an implanted perceval valve may experience valve folding when emergency cardiovascular procedures, such as cardiopulmonary resuscitation, are administered post-implant. the manufacturer will be providing clarifications about this potential adverse event related to the perceval valve and recommendations to prevent its occurrence. it will have an in-person meeting with the physicians implanting perceval to discuss key procedural steps to be followed to reduce the occurrence of stent folding, and to provide further information for an early detection of the phenomenon. there are no required actions for patients already implanted with perceval outside of normal monitoring and treatment. in the meantime, the affected users are reminded of the importance of the following key points, as indicated in the instructions for use (ifu), for prevention and early detection of stent folding: prevention decalcification, to avoid uneven surfaces; correct sizing, using available information in the ifu; ballooning, with the recommendation to pour warm sterile saline (at 37°c) while ballooning. early detection visual inspection, checking that the perceval stent is correctly deployed; performing an intraoperative echographic evaluation after perceval implant to confirm correct positioning and verify valve functionality under beating heart conditions. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 25 june 2018.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: LivaNova Perceval Sutureless Heart Valve
  • Manufacturer

Manufacturer